ARTICLE | Company News
Astellas, Roche deal
December 6, 2010 8:00 AM UTC
Roche said it and Astellas' OSI Pharmaceuticals Inc. subsidary plan to co-develop a PCR-based companion diagnostic for Tarceva erlotinib to identify EGFR activating mutations in non-small cell lung...